FI
Fischer Medical Ventures Ltd (FISCHER)
₹33.27
Mkt cap
₹2,316 Cr
P/E ratio
94.60
P/B
5.66
Div yield
0.15%
ROE
8.59%
ROCE
11.40%
EPS (TTM)
₹0.35
Book value
₹6
52W range
31–122
Sector
Healthcare
Price history
Previous close
Fischer Medical Ventures Ltd, earlier known as Fischer Chemic Ltd, leads a healthcare-technology group. It makes and services medical-imaging equipment and provides AI-based health screening and digital-health solutions. Its MRI manufacturing plant is located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. [1]
NSE FISCHERBSE 524743
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthHigh
TechnicalsBearish
52-week range
−72.66% from high₹33
₹31+7.15% from low₹122
Current
₹33.27
Prev close
₹32.85
Day
+1.28%
Price performance
1D
+1.28%
1W
−2.38%
1M
−10.15%
3M
−11.37%
6M
−18.13%
1Y
−70.76%
YTD
−20.46%
Financials
Revenue, profit & margin
P/E ratio
94.6×
FISCHER is 186% above the sector median of 33.1×
FISCHER94.6×
Sector median33.1×
| Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 20.79 | 10.12 | 39.66 | 11.75 | 49.17 | 23.44 | 86.31 | 101.10 | 97.54 | 81.92 | |
| Expenses | 0.00 | 18.28 | 10.33 | 39.16 | 11.38 | 46.66 | 19.45 | 70.09 | 79.53 | 101.31 | 70.67 | |
| Operating Profit | 0.00 | 2.51 | -0.21 | 0.50 | 0.37 | 2.51 | 3.99 | 16.22 | 21.57 | -3.77 | 11.25 | |
| OPM % | 12.07% | -2.08% | 1.26% | 3.15% | 5.10% | 17.02% | 18.79% | 21.34% | -3.87% | 13.73% | ||
| Other Income | 0.00 | 0.47 | 0.69 | 0.05 | 0.38 | 0.15 | 7.47 | 2.48 | 1.09 | 0.77 | 1.48 | |
| Interest | 0.00 | 0.05 | 0.13 | 0.05 | 0.07 | 0.23 | 0.66 | 0.92 | 0.64 | 3.66 | 3.54 | |
| Depreciation | 0.00 | 0.18 | 0.28 | 0.29 | 0.56 | 0.51 | 0.77 | 0.51 | 0.77 | 0.93 | 1.36 | |
| Profit before tax | 0.00 | 2.75 | 0.07 | 0.21 | 0.12 | 1.92 | 10.03 | 17.27 | 21.25 | -7.59 | 7.83 | |
| Tax % | 6.18% | 271.43% | -38.10% | 350.00% | 26.04% | 51.55% | 19.46% | 9.18% | 64.03% | 51.60% | ||
| Net Profit | 0.00 | 2.59 | -0.12 | 0.29 | -0.29 | 1.31 | 4.86 | 13.90 | 19.23 | -12.44 | 3.79 | |
| EPS in Rs | 0.00 | 0.05 | -0.00 | 0.01 | -0.01 | 0.02 | 0.07 | 0.21 | 0.30 | -0.19 | 0.06 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −3.55% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26◦ |
| Earnings day | −3.55% |
| +1 day | −1.32% |
| +5 days | −5.62% |
| +15 days | −7.56% |
| +30 days | −12.84% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Aug 202663.09%Promoter
Promoters63.09%0.94
FIIs5.57%0.09
DIIs1.26%0.09
Public30.09%0.92
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Poly Medicure | ₹1,726.00 | 54.67 | 17,495 | 0.20% | 85 | −7.57% | 525 | +30.30% | 12.50% |
| Molbio Diagnosti | ₹1,288.30 | 59.47 | 14,846 | 0.00% | 53 | +347.79% | 408 | +309.57% | 18.48% |
| Fischer Medical | ₹33.15 | 94.61 | 2,316 | 0.15% | 4 | −22.02% | 82 | +249.49% | 11.38% |
| Tarsons Products | ₹306.10 | 137.55 | 1,629 | 0.00% | −1 | −180.90% | 110 | +20.67% | 4.59% |
| Q-Line Biotech | ₹696.95 | 28.79 | 1,626 | 0.00% | 34 | +147.29% | 198 | −8.59% | 22.46% |
| Laxmi Dental | ₹197.95 | 31.32 | 1,089 | 0.00% | 10 | +22.77% | 75 | +13.87% | 15.05% |
| Vasa Denticity | ₹420.40 | 60.26 | 729 | 0.00% | 4 | +45.99% | 82 | +36.90% | 9.21% |
| Median: 17 Co. | ₹342.40 | 33.09 | 603 | 0.00% | 4 | +19.77% | 75 | +21.48% | 15.14% |
Filings
Annual reports15
Concall transcripts5
Announcements5
Presentation Of Investor/Analyst Meeting 17 SepChairman''s Message 16 Sep - Chairman’s letter reviews global expansion, new products, Vecura collaboration, and ₹59.67 crore promoter infill.Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Sep - Newspaper Advertisement for completion of dispatch, of Annual Report FY 2025-26, to ShareholdersBusiness Responsibility and Sustainability Reporting (BRSR) 7 Sep - FY2025-26 Business Responsibility and Sustainability Report filed on September 7, 2026.Reg. 34 (1) Annual Report. 7 Sep - Submitted FY2025-26 annual report; AGM scheduled for September 29, 2026, via online/VC.